+462.0%
MRNA vs HAS
+18.8%
+443.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.3% | -0.6% | +0.5% |
| 7D | -8.2% | -3.1% | -5.2% | -7.8% |
| 30D | +125.6% | -6.4% | +131.9% | +127.7% |
| 3M | +197.1% | +10.4% | +186.7% | +193.1% |
| 6M | +148.5% | -3.7% | +152.2% | +150.6% |
| YTD | +363.3% | +12.5% | +350.8% | +336.1% |
| 1Y | +462.0% | +19.8% | +442.1% | +427.4% |
| All | +462.0% | +18.8% | +443.2% | +427.4% |
Cumulative growth
Daily Returns
Daily percentage return beside HAS.
Daily Out/Under-Performance
Portfolio return minus HAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling